Virtual Medical Centre

Alzheimer's Disease Prevention May Be Easier Than Cure

Mayo Clinic Jacksonville researchers report evidence to suggest that prevention of amyloid beta (Abeta) deposition in the brain prior to Alzheimer's disease (AD) onset may be easier than curing established disease. An immunization strategy targeting Abeta42, or a second form of Abeta known as Abeta40, prevented onset of amyloid deposition in young, AD-prone mice. However, this strategy was not effective in altering Abeta deposition or clearance in mice with modest levels of preexisting Abeta deposits.

Current hypotheses suggest that it is the accumulation over time of amyloid beta peptide 1–42 (Abeta42) that triggers changes in the brain that lead to cognitive dysfunction in Alzheimer's disease. The reduction of amyloid levels is therefore a major therapeutic objective. Todd Golde and colleagues from the Mayo Clinic Jacksonville report evidence to suggest that prevention of amyloid deposition may be easier than curing established Alzheimer's disease. Their results will appear online on December 8 in advance of print publication in the January 2006 issue of the Journal of Clinical Investigation.

The authors use transgenic mice genetically predisposed to accumulate amyloid deposits in their brain to show that an immunization strategy targeting Abeta42, or a second form of Abeta known as Abeta40, prevents the onset of amyloid deposition in these mice at a young age. In contrast, the anti-Abeta42 or anti-Abeta40 monoclonal antibodies were not effective in altering Abeta deposition in mice with modest levels of preexisting Abeta deposits, nor were they capable of clearing existing deposits.

The results suggest that it may be easier to prevent Abeta deposition than to alter Abeta once deposited. This method may be an effective strategy to prevent amyloid deposition prior to the onset of Alzheimer's disease, but may have limited benefit in a therapeutic setting where amyloid deposits are already well established within the brain.

(Source: Journal of Clinical Investigation: Mayo Clinic Jacksonville: December 2005.)

Related Articles:

• Test quickly assesses whether Alzheimer's drugs are hitting their target
• Brain scans demonstrate link between education and Alzheimer's
• Mind aerobics fight dementia
• Alzheimer's and parkinson's under the microscope
• Getting forgetful? Then blueberries may hold the key
• Hormone not helpful against Alzheimer’s
• Injectable Antibody may Attack some Alzheimer's Symptoms
• Frequent Brain Stimulation in Old Age Reduces Risk of Alzheimer's Disease
• Omega-3 Supplements Affect Alzheimer's Symptoms
• Blocking Stress Protein Decreases Alzheimer's Peptide in Mice
• Enzyme Family Plays Role In Alzheimer's: University Of Toronto Study
• New Strategy For Protecting Brain Against Alzheimer's Disease: Enhancing The Innate Immune System
• OHSU Researchers Demonstrate How Alzheimer's Disease Impacts Important Brain Cell Function
• Neuronal Death And Processing Of Tau Protein In Alzheimer's Disease
• Duke Chemists Isolating Individual Molecules Of Toxic Protein In Alzheimer's, Parkinson's Disease

Article Tools:

E-mail

Print

Twitter

Facebook

Article Comments

Rate this article